Who Owns CooperVision?

CooperVision operates a plastic neutrality program in partnership with Plastic Bank, launched in 2021. The program funds the collection and recycling of ocean-bound plastic equivalent to the weight of plastic used in participating CooperVision soft contact lens products, including the lens, blister, and packaging. As of January 2024, CooperVision reported collecting approximately 5.3 million kilograms of plastic through this partnership. The program covers 27 countries across the Americas, Europe, and Asia-Pacific. CooperVision states it is the first contact lens manufacturer to provide a full range of plastic neutral soft contact lenses.

Several CooperVision manufacturing sites hold green building certifications. The Alajuela and Coyol, Costa Rica facilities are LEED Gold certified. The Juana Diaz, Puerto Rico site is LEED Gold certified. The Scottsville and West Henrietta, New York sites are LEED Silver certified. The Mount Park, United Kingdom facility holds a BREEAM certification. A Madrid, Spain office is LEED certified.

CooperVision has not announced a formal net-zero target or science-based emissions reduction commitment as of August 2026. The company's sustainability reporting focuses on manufacturing efficiency, waste reduction, and the plastic neutrality program rather than comprehensive carbon accounting.

CooperVision's MiSight 1 day received FDA approval in November 2019 as the first soft contact lens to slow myopia progression in children aged 8 to 12. This regulatory milestone is documented in FDA clearance records and represents a category-defining approval. MiSight subsequently received approval from China's NMPA in August 2021 and from Japanese regulators.

The Biofinity family was named the best overall contact lens family by ContactLens.com's 2026 best contact lenses guide, recognized for covering standard, toric, and multifocal prescriptions within a single silicone hydrogel platform. Biofinity Multifocal was named best multifocal contact lens by Vision Center's 2026 eye doctor survey.

CooperVision's manufacturing facilities in Costa Rica and Puerto Rico have received LEED Gold certification from the U.S. Green Building Council, recognizing energy and environmental design standards.

CooperVision has issued several voluntary Class II recalls in 2024 and 2025, all managed through standard FDA recall procedures. In February 2025, the company recalled 33,990 MyDay Toric lenses (FDA recall Z-1455-2025) due to incorrect cylinder power in a limited number of lots. The recall affected lenses sold under multiple brand names including MyDay Toric, Kirkland Signature Toric Premium Daily Disposable, and various private label versions.

In June 2025, CooperVision recalled Biofinity XR Toric lenses (Z-2165-2025, 397 units) and Biofinity Toric Multifocal lenses (Z-2166-2025) due to blister seals that were incomplete or leaking, potentially rendering lenses unsterile. In August 2025, the company recalled MyDay Toric lenses (Z-2606-2025, 4,140 units), Sofmed Breathables (Z-2607-2025, 180 units), and Voyant 1-Day Premium Toric (Z-2608-2025) due to an invalid sterilization cycle in one lot. An earlier August 2024 recall affected 607 Biofinity XR Toric lenses (Z-3310-2024) due to a misaligned axis causing incorrect power.

All of these recalls were classified as Class II by the FDA, meaning the products could cause temporary adverse health consequences but were unlikely to cause permanent injury. No deaths or permanent injuries have been reported in connection with these recalls. The recall volumes were small relative to CooperVision's total production, and each was limited to specific lot numbers.

No major FDA Warning Letters have been issued to CooperVision manufacturing facilities as of August 2026, per publicly available FDA inspection records.